HPV-related head and neck cancer is one of the fastest-growing cancers in the United States, particularly among younger adults who have never smoked. Most commonly affecting the tonsils and base of the tongue, these cancers often present with few symptoms beyond a persistent neck lump, which can delay diagnosis. When detected early, however, HPV-related oropharyngeal cancers have cure rates exceeding 80% to 90%.
UT Health San Antonio Multispecialty and Research Hospital offers advanced transoral robotic surgery (TORS) using the newest-generation single-port robotic system, which is specifically designed and FDA-approved for head and neck surgery. The minimally invasive approach allows surgeons to remove select tumors through the mouth without external incisions while using a high-definition, three-dimensional camera and robotic instruments that provide enhanced visualization and surgical precision. For appropriately selected patients, TORS may help reduce the need for chemotherapy or high-dose radiation while preserving speech, swallowing and long-term quality of life.
Not every patient is a candidate for robotic surgery. Every head and neck cancer case is reviewed by a multidisciplinary team of surgeons, medical oncologists, radiation oncologists, radiologists, speech-language pathologists and rehabilitation specialists to determine the safest and most effective treatment plan for each individual patient. This collaborative approach helps ensure patients receive personalized care based on their cancer, anatomy and overall health.
Connected to the National Cancer Institute-designated Mays Cancer Center, patients at UT Health San Antonio Multispecialty and Research Hospital have access to one of the region's most experienced head and neck robotic surgery programs.
For patients, advanced robotic technology, multidisciplinary expertise and early evaluation can improve cancer outcomes while preserving speech, swallowing and long-term quality of life.